Beijng Immunoah Pharma Tech Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Beijng Immunoah Pharma Tech Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors (NCT06292858) | Beijng Immunoah Pharma Tech Co., Ltd. | 2023-02-24 |
Track Beijng Immunoah Pharma Tech Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.